Trial intelligence / Profile preview

Meloxicam vs Diclofenac in Knee Osteoarthritis

NCT02183129Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Apr 1999
Primary completion
Nov 1999
Modality
Small Molecules
01

Overview

A Phase 4 trial of meloxicam in osteoarthritis (OA), sponsored by Boehringer Ingelheim. Started Apr 1999; status: completed.

02

Drugs

meloxicam
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT02183129.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02183129.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call